Network Radiology, a leading independent radiology center and teleradiology service provider in Cleveland, is using Exa PACS/RIS from Konica Minolta Healthcare Americas Inc. to help increase productivity and enable high reading volumes for both business applications. With a growing number of imaging studies between the two business segments, Network Radiology relies on Exa PACS server-side rendering and the solution’s diagnostic-quality zero footprint universal viewer for fast access to imaging studies from virtually any location, workstation or modality.

University of Iowa Health Care recently purchased Carestream’s Vue Motion enterprise viewer, lesion management and mammography/tomography software to augment the capabilities of its existing Carestream Clinical Collaboration Platform.

Radiation therapy following mastectomy for intermediate-stage, high-risk breast cancer can be shortened from five to three weeks while maintaining tumor control rates in the breast and surrounding region that are equivalent to conventional treatment, according to new research. The findings were presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego.

In a new phase III trial report, recurrence-free and overall survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy plus chemotherapy when compared with pelvic radiation therapy. Risks of pelvic and para-aortic nodal recurrence and frequency of short-term side effects were greater for the brachytherapy-chemotherapy approach. High completion rates for each treatment arm suggest that both therapies are well-tolerated by patients. Findings from the report from the National Clinical Trial Network group, NRG Oncology, were presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego.